文献速递胸部肿瘤

立体定向放疗与胸腔镜手术引入后老年I期非小细胞肺癌治疗模式与生存变化

Changes in treatment patterns and survival in elderly patients with stage I non-small-cell lung cancer with the introduction of stereotactic body radiotherapy and video-assisted thoracic surgery.
PubMed 文献 · Eur J Cancer · 2018-07-14

基于荷兰癌症登记2168例≥65岁临床I期NSCLC患者,比较2004-2008与2009-2013两个时期。手术切除率无差异,放疗比例增加(SBRT大幅上升),未治疗者减少;全组中位OS从31个月改善至42个月,手术患者长期OS最高。

要点

  • 老年I期NSCLC中手术切除率保持稳定,放疗比例增加且SBRT应用显著上升。
  • 全组中位OS从31个月改善至42个月,未治疗患者比例下降。
  • 手术患者5年OS达57%,显著高于放疗患者的23%。

核心结论

  • 老年I期NSCLC中手术使用保持稳定,放疗增加,未治疗者减少,全组中位OS改善,手术与最高长期OS相关。

研究设计与样本

  • 基于荷兰癌症登记数据的回顾性队列分析,纳入2168例≥65岁临床I期NSCLC患者,比较2004-2008年(A期)与2009-2013年(B期)两个时期。

主要发现

  • A期与B期切除率无差异(51% vs 53%;p=0.37),但B期VATS比例显著更高(0% vs 32%;p<0.001)。
  • 放疗应用增加(26% vs 33%;p=0.001),其中SBRT大幅增加(3% vs 63%;p<0.001)。
  • 未接受手术或放疗的患者比例下降(23% vs 14%;p<0.001)。
  • 全组中位OS显著改善(31 vs 42个月;p=0.001),放疗患者中位OS亦改善(23 vs 33个月;p=0.02),手术患者中位OS无显著差异(65 vs 74个月;p=0.16)。
  • 多因素分析中,手术患者A期较B期死亡风险增加(HR 1.20;95%CI 1.01-1.43),放疗患者无显著差异(HR 1.19;95%CI 0.99-1.43);手术患者5年OS为57%,放疗患者为23%。

临床怎么用

  • 老年I期NSCLC应综合评估后选择手术或SBRT,手术与最高长期OS相关,SBRT为放疗主要模式且应用增加。

局限性

  • 为回顾性登记研究,可能存在选择偏倚和混杂因素,未报告具体合并症及体能状态等细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The optimal treatment of elderly patients with early-stage non-small-cell lung cancer (NSCLC) remains elusive. Still, the introduction of video-assisted thoracic surgery (VATS) and stereotactic body radiotherapy (SBRT) may have led to more elderly receiving treatment and improved median overall survival (OS). MATERIALS AND METHODS: We analysed data from the Netherlands Cancer Registry of 2168 patients ≥65 years with clinical stage I NSCLC and distinguished two periods: 2004-2008 (A) and 2009-2013 (B). The analyses focussed on treatment patterns and median OS for patients receiving surgery, radiotherapy or neither surgery nor radiotherapy. Furthermore, we explored the influence of the application of VATS and SBRT. RESULTS: The resection rate did not differ between the periods A and B (51% versus 53%; p = 0.37), despite significantly more VATS procedures in the latter period (0% versus 32%; p < 0.001). Application of radiotherapy increased (26% versus 33%; p = 0.001), especially SBRT (3% versus 63%; p < 0.001). The proportion of patients receiving neither therapy decreased (23% versus 14%; p < 0.001). Median OS for all patients significantly improved (31 versus 42 months; p = 0.001), and also for those receiving radiotherapy (23 versus 33 months; p = 0.02), but not significantly for surgical patients (65 versus 74 months; p = 0.16). Still, in multivariable analysis, surgical patients had an increased risk of death in period A compared with period B (hazard ratio [HR] 1.20; 95% confidence interval [CI], 1.01-1.43); this was not the case for patients receiving radiotherapy (HR 1.19; 95% CI, 0.99-1.43). Five-year OS was 57% for surgical patients and 23% for those receiving radiotherapy. CONCLUSION: In elderly patients with stage I NSCLC, the use of surgery remained constant, that of radiotherapy increased and fewer patients received neither treatment over the years. Median OS improved for all patients; surgery was associated with the highest long-term OS.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Detillon DDEMA, Driessen EJM, Aarts MJ, et al. Changes in treatment patterns and survival in elderly patients with stage I non-small-cell lung cancer with the introduction of stereotactic body radiotherapy and video-assisted thoracic surgery. Eur J Cancer. 2018. PMID: 30014972. doi:10.1016/j.ejca.2018.06.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。